M Pfeffer
Impact in
- Nephrology top 1%
- Dialysis and Renal Disease Management
- Chronic Kidney Disease and Diabetes
- Transplantation top 5%
- Renal Transplantation Outcomes and Treatments
Papers in
- Pharmacology 14
- Antibiotics Pharmacokinetics and Efficacy 11
- Pharmacology and Obesity Treatment 2
- Pharmacogenetics and Drug Metabolism 2
- Co-authors
- M J KlagGarabed EknoyanAndrew S. LeveyB.L. KasiskePeter W. WilsonStephen H. WeinsteinKelly PittmanComis Rl
- Journals
- Antimicrobial Agents and Chemotherapy (7 papers)Journal of Pharmaceutical Sciences (4 papers)Infection (1 paper)British Journal of Clinical Pharmacology (1 paper)Nature (1 paper)
- Partner nations
- United StatesGermanyItaly
In The Last Decade
M Pfeffer
27 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Nephrology 449
- Transplantation 93
- Cardiology and Cardiovascular Medicine 325
- Orthodontics 50
- Pharmacology 143
Countries citing papers authored by M Pfeffer
This map shows the geographic impact of M Pfeffer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Pfeffer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Pfeffer more than expected).
Fields of papers citing papers by M Pfeffer
This network shows the impact of papers produced by M Pfeffer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Pfeffer. The network helps show where M Pfeffer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M Pfeffer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 52 | |
| 2 | Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease Hit paper breakdown → | 1998 | 760 |
| 3 | 1994 | 21 | |
| 4 | 1992 | 26 | |
| 5 | In-vitro and in-vivo characterisation of two sustained release formulations for the antidepressant rolipram. | 1990 | 1 |
| 6 | 1988 | 1 | |
| 7 | 1988 | 16 | |
| 8 | 1987 | 11 | |
| 9 | 1986 | 2 | |
| 10 | Bioavailability and pharmacokinetics of etoposide (VP-16). | 1985 | 78 |
| 11 | 1984 | 24 | |
| 12 | 1982 | 24 | |
| 13 | 1982 | 9 | |
| 14 | Biological disposition of 8-methoxsalen in rat and man. | 1980 | 6 |
| 15 | 1980 | 46 | |
| 16 | 1980 | 2 | |
| 17 | Metabolism and pharmacokinetics of naloxone. | 1973 | 27 |
| 18 | 1973 | 35 | |
| 19 | 1971 | 41 | |
| 20 | 1971 | 18 |
About M Pfeffer
M Pfeffer is a scholar working on Pharmacology, Applied Microbiology and Biotechnology, Emergency Medicine, Transplantation and Pharmacology, having authored 28 papers that have together received 1.3k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (11 papers), Drug Transport and Resistance Mechanisms (5 papers), Poisoning and overdose treatments (3 papers), Analytical Methods in Pharmaceuticals (3 papers), Analytical Chemistry and Chromatography (2 papers), Pharmacology and Obesity Treatment (2 papers), Pneumonia and Respiratory Infections (2 papers) and Pharmacogenetics and Drug Metabolism (2 papers). The work is most often cited by research in Nephrology (449 citations), Transplantation (93 citations), Cardiology and Cardiovascular Medicine (325 citations), Orthodontics (50 citations) and Pharmacology (143 citations). M Pfeffer has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include M J Klag, Garabed Eknoyan, Andrew S. Levey, B.L. Kasiske, Peter W. Wilson, Stephen H. Weinstein, Kelly Pittman, Comis Rl, Anthony J. Scalzo and Robert D. Smyth. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Pharmaceutical Sciences, Infection, British Journal of Clinical Pharmacology and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.